tiprankstipranks
Trending News
More News >
Advertisement
Advertisement

Inspira Technologies’ ART100 System Adopted for Lung Transplants by Leading U.S. Hospital

Story Highlights
  • Inspira Technologies’ ART100 system is now used in lung transplants by a top U.S. hospital.
  • The expansion validates the ART100’s performance and boosts Inspira’s industry standing.
  • Looking for the best stocks to buy? Follow the recommendations of top-performing analysts.
Inspira Technologies’ ART100 System Adopted for Lung Transplants by Leading U.S. Hospital

Elevate Your Investing Strategy:

  • Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.

Inspira Technologies Oxy BHN ( (IINN) ) just unveiled an update.

On September 2, 2025, Inspira Technologies announced that a top U.S. hospital has expanded the use of its INSPIRA ART100 system to lung transplant procedures, following positive prior experiences. This expansion into one of the most demanding applications in advanced respiratory care signifies strong validation of the system’s performance and clinical value, potentially establishing it as a standard in complex surgical settings. The move also reflects the growing confidence in Inspira’s technology and aligns with the company’s recent commercial momentum, including multi-million dollar government orders.

The most recent analyst rating on (IINN) stock is a Buy with a $2.00 price target. To see the full list of analyst forecasts on Inspira Technologies Oxy BHN stock, see the IINN Stock Forecast page.

Spark’s Take on IINN Stock

According to Spark, TipRanks’ AI Analyst, IINN is a Underperform.

The overall stock score reflects significant financial instability, as indicated by ongoing losses and reliance on external funding. The technical analysis shows bearish sentiment, with the stock under pressure. Valuation is challenging due to negative earnings and lack of dividend yield, making the stock less appealing to investors.

To see Spark’s full report on IINN stock, click here.

More about Inspira Technologies Oxy BHN

Inspira Technologies Oxy B.H.N. Ltd. is a commercial-stage medical device company specializing in advanced respiratory support and real-time blood monitoring solutions. The company’s INSPIRA ART100 system is FDA-cleared for cardiopulmonary bypass in the U.S. and ECMO procedures outside the U.S. Inspira is also developing the INSPIRA ART500 and the HYLA blood sensor platform, positioning itself as a significant player in the life-support and MedTech landscape.

Average Trading Volume: 1,149,666

Technical Sentiment Signal: Buy

Current Market Cap: $29.46M

For an in-depth examination of IINN stock, go to TipRanks’ Overview page.

Disclaimer & DisclosureReport an Issue

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App
1